Author:
Chandra Jagetia Ganesh,Jyothi P
Subject
Health, Toxicology and Mutagenesis,Genetics
Reference36 articles.
1. Sweeny, M.J., G.B. Boder, G.J. Cullinan, H.W. Culp, W.D. Daniels, W.D. Dyke, R.W. Gerzon, K. McMahon, R.E. Nelson, G.A. Poore and G.C. Todd (1978) Antitumour activity of desacetyl vinblastinamide sulphate (vindesine) in rodents and mitotic accumulation studies in culture, Cancer Res., 38, 2886–2891.
2. Mandelli, F., S. Amadori, F. Giona, M. Antonietta, A. Spiriti, S. Pastore, G. Meloni and G. Paolucci (1982) Vindesine in the treatment of refractory haemolytic malignancies, a phase II study, Leukemia Res., 6, 649–652.
3. Krivit, W., R. Chilcote, A. Pyesmany, J. Anderson and D. Hammond (1979) An initial report of a phase III trial comparing vindesine and vincristine for acute leukemia of childhood, Cancer Chemother. Pharmacol., 2, 267–270.
4. Garewal, H.S., R.J. Brooks, S.E. Jones and T.P. Miller (1983) Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine, J. Clin. Oncol., 1, 772–775.
5. Houwen, B., Th. Ockahuizen, J. Marrink and H.O. Nie Weg (1981) Vindesine therapy melphalan resistant multiple myeloma, Eur. J. Cancer, 17, 227–232.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献